SEBSA Biosafety Symposium
Advarra is sponsoring the Southeastern Biological Safety Association’s (SEBSA) Symposium. At this event, we will discuss current topics in clinical biosafety and network with peers. Join our session:
Overview of Recent FDA Guidance Documents Pertinent to IBC Review of Clinical Trials Involving Recombinant or Synthetic Nucleic Acid Molecules
Friday, May 20 at 9 am ET
Presented by:
Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP
Executive Director, Biosafety Services
Daniel holds a PhD in Molecular Biology and Immunology, as well as various professional certifications in biological safety, and is a regular speaker at research conferences.
IBC review and oversight are essential for mitigating risks when conducting clinical trials involving genetically engineered treatments and vaccines. Contact us to learn more about our IBC services.
